Kevin M. Brennan, SVP of Xilio Therapeutics XLO, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $1,169. The latest trade was on 01/02.

KB

KB

Kevin M. Brennan

SVP, Finance and Accounting

Company

Xilio Therapeutics XLO

First filing

23/04/03

Trades

20 trades

Buys / sales

0 / 2

12-month net buying

−$1,169

Last trade

01/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xilio TherapeuticsXLO	Open-market sale10b5-1 plan	01/02	01/05	1,826 sh	$0.64	$1,168.64	−22.3%
Xilio TherapeuticsXLO	Open-market sale10b5-1 plan	25/01/02	25/01/03	1,803 sh	$0.98	$1,766.94	−36.1%